Maternal SARS-CoV-2 vaccination in early-third trimester may optimize neonatal seroprotection

By | September 7, 2021
Researchers in Israel have conducted a study showing that vaccinating pregnant women against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) early on in the third trimester may maximize transplacental antibody transfer, potentially helping to prevent severe coronavirus disease 2019 (COVID-19) during infancy.